- Home
- ESQ vs TRVI Comparison
ESQ vs TRVI Comparison
Compare ESQ & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ESQ
- TRVI
- Stock Information
- Founded
- ESQ 2006
- TRVI 2011
- Country
- ESQ United States
- TRVI United States
- Employees
- ESQ N/A
- TRVI N/A
- Industry
- ESQ Commercial Banks
- TRVI Biotechnology: Pharmaceutical Preparations
- Sector
- ESQ Finance
- TRVI Health Care
- Exchange
- ESQ Nasdaq
- TRVI Nasdaq
- Market Cap
- ESQ 756.3M
- TRVI 629.8M
- IPO Year
- ESQ 2017
- TRVI 2019
- Fundamental
- Price
- ESQ $92.00
- TRVI $5.66
- Analyst Decision
- ESQ Hold
- TRVI Strong Buy
- Analyst Count
- ESQ 3
- TRVI 8
- Target Price
- ESQ $95.00
- TRVI $19.31
- AVG Volume (30 Days)
- ESQ 117.2K
- TRVI 2.5M
- Earning Date
- ESQ 07-24-2025
- TRVI 08-07-2025
- Dividend Yield
- ESQ 0.77%
- TRVI N/A
- EPS Growth
- ESQ 13.51
- TRVI N/A
- EPS
- ESQ 5.27
- TRVI N/A
- Revenue
- ESQ $124,132,000.00
- TRVI N/A
- Revenue This Year
- ESQ N/A
- TRVI N/A
- Revenue Next Year
- ESQ $10.72
- TRVI N/A
- P/E Ratio
- ESQ $17.26
- TRVI N/A
- Revenue Growth
- ESQ 14.72
- TRVI N/A
- 52 Week Low
- ESQ $45.14
- TRVI $2.36
- 52 Week High
- ESQ $94.90
- TRVI $7.48
- Technical
- Relative Strength Index (RSI)
- ESQ 56.16
- TRVI 38.66
- Support Level
- ESQ $88.47
- TRVI $5.53
- Resistance Level
- ESQ $94.90
- TRVI $5.96
- Average True Range (ATR)
- ESQ 2.30
- TRVI 0.33
- MACD
- ESQ -0.10
- TRVI -0.08
- Stochastic Oscillator
- ESQ 54.90
- TRVI 8.46
About ESQ Esquire Financial Holdings Inc.
Esquire Financial Holdings Inc is a financial holding company. Through its subsidiary, the company operates as a full-service commercial bank dedicated to serving the financial needs of the legal industry and small businesses nationally, as well as commercial and retail customers in the New York metropolitan area. The Bank offers tailored products and solutions to the legal community and their clients as well as dynamic and flexible payment processing solutions to small business owners. Banking products offered for businesses and consumers include checking, savings, money market, and time deposits; a wide range of commercial and consumer loans, as well as customary banking services. In addition, it operates a payment processing platform through third-party independent sales organizations.
About TRVI Trevi Therapeutics Inc.
Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.